Study links erectile dysfunction drug with skin cancer
A class of erectile dysfunction drugs that includes Viagra has been linked to a slight increase in the risk of the skin cancer melanoma, according to a study Tuesday. While the research in the Journal of the American Medical Association stops short of proving that the drugs cause melanoma, researchers said their findings warrant a closer look at medications known as PDE5 (phosphodiesterase type 5) inhibitors. Of those patients, 11 percent had filled at least one prescription for a PDE5 inhibitor to treat erectile dysfunction.
Patient Navigation Through Clinical Trials
Dr. Sapna Patel, medical oncologist, Martha Bishop and T.J. Sharpe, both melanoma survivors and patient advocates, discuss the process of finding a... Learn More